These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 17270269

  • 1. Reduced expression of FLIP SHORT in bone marrow of low risk myelodysplastic syndrome.
    de Melo Campos P, Traina F, da Silva Santos Duarte A, Lorand-Metze I, Costa FF, Saad ST.
    Leuk Res; 2007 Jun; 31(6):853-7. PubMed ID: 17270269
    [Abstract] [Full Text] [Related]

  • 2. Cell cycle and apoptosis regulatory gene expression in the bone marrow of patients with de novo myelodysplastic syndromes (MDS).
    Economopoulou C, Pappa V, Papageorgiou S, Kontsioti F, Economopoulou P, Charitidou E, Girkas K, Kapsimali V, Papasteriadi C, Tsirigotis P, Papageorgiou E, Dervenoulas J, Economopoulos T.
    Ann Hematol; 2010 Apr; 89(4):349-58. PubMed ID: 19813013
    [Abstract] [Full Text] [Related]

  • 3. Expression of FLIP(Long) and FLIP(Short) in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis.
    Benesch M, Platzbecker U, Ward J, Deeg HJ, Leisenring W.
    Leukemia; 2003 Dec; 17(12):2460-6. PubMed ID: 14562111
    [Abstract] [Full Text] [Related]

  • 4. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
    Qi H, Xiao L, Lingyun W, Ying T, Yi-Zhi L, Shao-Xu Y, Quan P.
    Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
    [Abstract] [Full Text] [Related]

  • 5. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L, Vidriales MB, García-Laraña J, Sanz G, Moreno MJ, López A, Barrena S, Martínez R, Tormo M, Palomera L, Lavilla E, López-Berges MC, de Santiago M, de Equiza ME, Miguel JF, Orfao A.
    Clin Cancer Res; 2004 Nov 15; 10(22):7599-606. PubMed ID: 15569991
    [Abstract] [Full Text] [Related]

  • 6. Increased expression of APAF-1 in low-risk myelodysplastic syndrome: a possible role in the pathophysiology of myelodysplasia.
    Benites BD, Traina F, Duarte Ada S, Lorand-Metze IG, Costa FF, Saad ST.
    Eur J Haematol; 2010 Jun 15; 84(6):525-30. PubMed ID: 20345447
    [Abstract] [Full Text] [Related]

  • 7. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
    Gianelli U, Fracchiolla NS, Cortelezzi A, Pellegrini C, Savi F, Moro A, Grimoldi MG, Deliliers GL, Coggi G, Bosari S.
    Ann Hematol; 2007 Mar 15; 86(3):185-9. PubMed ID: 17124585
    [Abstract] [Full Text] [Related]

  • 8. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G, Heiss S, Gastl G, Tzankov A, Stauder R.
    Eur J Haematol; 2005 Dec 15; 75(6):485-91. PubMed ID: 16313260
    [Abstract] [Full Text] [Related]

  • 9. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
    Greco M, D'Alò F, Scardocci A, Criscuolo M, Fabiani E, Guidi F, Di Ruscio A, Migliara G, Pagano L, Fianchi L, Chiusolo P, Hohaus S, Leone G, Voso MT.
    Blood Cells Mol Dis; 2010 Oct 15; 45(3):181-5. PubMed ID: 20655775
    [Abstract] [Full Text] [Related]

  • 10. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia.
    Xu K, Wang L, Hao Y, Shao Z, Meng Q, Li K, Chao H, Tang K, Wang L.
    Chin Med J (Engl); 1999 Dec 15; 112(12):1112-8. PubMed ID: 11721451
    [Abstract] [Full Text] [Related]

  • 11. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
    Maratheftis CI, Bolaraki PE, Voulgarelis M.
    Am J Hematol; 2007 Oct 15; 82(10):887-92. PubMed ID: 17570514
    [Abstract] [Full Text] [Related]

  • 12. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
    Kurotaki H, Tsushima Y, Nagai K, Yagihashi S.
    Acta Haematol; 2000 Oct 15; 102(3):115-23. PubMed ID: 10692673
    [Abstract] [Full Text] [Related]

  • 13. Expression dynamics of drug resistance genes, multidrug resistance 1 (MDR1) and lung resistance protein (LRP) during the evolution of overt leukemia in myelodysplastic syndromes.
    Kurata M, Hasegawa M, Nakagawa Y, Abe S, Yamamoto K, Suzuki K, Kitagawa M.
    Exp Mol Pathol; 2006 Dec 15; 81(3):249-54. PubMed ID: 16566920
    [Abstract] [Full Text] [Related]

  • 14. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB, Pardo ML, Pavlovsky MA, Fernandez I, Corrado CS, Giere I, Sapia S, Pavlovsky S.
    Cytometry B Clin Cytom; 2006 Mar 15; 70(2):63-70. PubMed ID: 16470534
    [Abstract] [Full Text] [Related]

  • 15. Analysis of apoptosis regulatory genes expression in the bone marrow (BM) of adult de novo myelodysplastic syndromes (MDS).
    Economopoulou C, Pappa V, Kontsioti F, Papageorgiou S, Kapsimali V, Papasteriadi C, Economopoulou P, Papageorgiou E, Dervenoulas J, Economopoulos T.
    Leuk Res; 2008 Jan 15; 32(1):61-9. PubMed ID: 17597205
    [Abstract] [Full Text] [Related]

  • 16. Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome.
    Brada SJ, van de Loosdrecht AA, Koudstaal J, de Wolf JT, Vellenga E.
    Leuk Res; 2004 Sep 15; 28(9):921-5. PubMed ID: 15234568
    [Abstract] [Full Text] [Related]

  • 17. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
    Wu LY, Li X, Chang CK, Ying SX, Pu Q.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug 15; 28(8):549-54. PubMed ID: 18078133
    [Abstract] [Full Text] [Related]

  • 18. Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
    Keith T, Araki Y, Ohyagi M, Hasegawa M, Yamamoto K, Kurata M, Nakagawa Y, Suzuki K, Kitagawa M.
    Br J Haematol; 2007 May 15; 137(3):206-15. PubMed ID: 17408459
    [Abstract] [Full Text] [Related]

  • 19. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
    Bernasconi P.
    Br J Haematol; 2008 Sep 15; 142(5):695-708. PubMed ID: 18540941
    [Abstract] [Full Text] [Related]

  • 20. Absence or low expression of fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome.
    Tourneur L, Delluc S, Lévy V, Valensi F, Radford-Weiss I, Legrand O, Vargaftig J, Boix C, Macintyre EA, Varet B, Chiocchia G, Buzyn A.
    Cancer Res; 2004 Nov 01; 64(21):8101-8. PubMed ID: 15520222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.